ViewRay® Newsroom

ViewRay® to Present at The JMP Securities Life Sciences Conference

June 13, 2017

CLEVELAND, June 13, 2017 — ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer is scheduled to present at The JMP Securities Life Sciences Conference in New York, NY. 

Event: The JMP Securities Life Sciences Conference
Date: Tuesday, June 20
Time: 2:00pm ET

An audio webcast of the Company’s presentation will be available on the investor relations section of ViewRay’s website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.

About ViewRay

ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Contact:

Michael Saracen
Senior Director, Marketing
ViewRay, Inc.
Phone: +1 408-242-2994
Email: media@viewray.com

 


Copyright 2017 © ViewRay. All rights reserved   -   Contact ViewRay